Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Etodolac - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for etodolac?

Etodolac is the generic ingredient in three branded drugs marketed by Sandoz, Apotex Inc, Mylan, Teva, Apotex, Oxford Pharms, Wyeth Pharms Inc, Ani Pharms Inc, Ranbaxy Labs Ltd, Lehigh Valley, Watson Labs Florida, Zydus Pharms Usa Inc, Idt Australia Ltd, Chartwell Molecules, Chartwell Pharms Llc, Watson Labs, Taro, Taro Pharm Inds, Ivax Sub Teva Pharms, and Actavis Elizabeth, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for etodolac. Thirty-eight suppliers are listed for this compound.

Summary for Generic Name: etodolac

Tradenames:3
Patents:1
Applicants:20
NDAs:35
Drug Master File Entries: see list22
Suppliers / Packagers: see list38
Bulk Api Vendors: see list56
Clinical Trials: see list14
Patent Applications: see list8,631
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etodolac at DailyMed

Pharmacology for Ingredient: etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Idt Australia Ltd
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL075943-002Jul 26, 2002DISCNNoNo► Subscribe► Subscribe
Taro
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL076174-002Mar 13, 2003RXNoNo► Subscribe► Subscribe
Ani Pharms Inc
ETODOLAC
etodolac
CAPSULE;ORAL074899-001Jul 8, 1997DISCNNoNo► Subscribe► Subscribe
Idt Australia Ltd
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL075943-003Jul 26, 2002DISCNNoNo► Subscribe► Subscribe
Mylan
ETODOLAC
etodolac
TABLET;ORAL075012-001Sep 30, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-003Jan 20, 19984,966,768*PED► Subscribe
Wyeth Pharms Inc
LODINE
etodolac
CAPSULE;ORAL018922-002Jan 31, 19913,939,178► Subscribe
Wyeth Pharms Inc
LODINE
etodolac
TABLET;ORAL018922-004Jul 29, 19934,076,831► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-001Oct 25, 19964,966,768*PED► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-002Oct 25, 19964,966,768*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc